Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Investors realize that Lilly won’t lose money in product liability case
Marketwatch
Tue, 04/8/14 - 05:15 pm
Tags:
investors, Eli Lilly, Takeda, diabetes, Actos
US jury hits Takeda, Eli Lilly with $9 bln penalty
Yahoo/AP
Tue, 04/8/14 - 08:56 am
Tags:
Takeda, Actos, Eli Lilly, diabetes
Pfizer Breast Cancer Drug Helps Revive Discarded Strategy
Bloomberg
Mon, 04/7/14 - 08:46 am
Tags:
Pfizer, Eli Lilly, palbociclib, Novartis, bemaciclib, breast cancer, CDK 4/6 inhibitors
Lilly to present data from bemaciclib as potential treatment for breast cancer
Yahoo/Reuters
Mon, 04/7/14 - 08:40 am
Tags:
bemaciclib, Eli Lilly, metastatic breast cancer, CDK 4/6 inhibitors
Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?
Motley Fool
Thu, 04/3/14 - 09:41 am
Tags:
M&A, Ariad Pharmaceuticals, Eli Lilly, Iclusig, Jazz Pharmaceuticals, GSK
U.S. judge upholds validity of Eli Lilly's Alimta patent
Yahoo/Reuters
Mon, 03/31/14 - 10:34 pm
Tags:
Eli Lilly, Alimta, patents
Makings of a Wide Moat in Diabetes Care
Morningstar
Fri, 03/28/14 - 11:16 am
Tags:
diabetes, Takeda, Sanofi, GSK, Victoza, Merck, insulin, Novo Nordisk, Afrezza, U300, Tresiba, Eli Lilly
Zacks Industry Outlook Highlights: Eli Lilly, AstraZeneca, Shire, Salix and Cubist Pharmaceuticals
Yahoo/Zacks.com
Thu, 03/27/14 - 09:47 am
Tags:
Eli Lilly, Shire, Salix, AstraZeneca, Cubist Pharmaceuticals, M&A
Eli Lilly Says Most Employees Won't See Raises in Base Salary This Year
WSJ Online
Mon, 03/24/14 - 06:32 pm
Tags:
Eli Lilly, salaries
Boehringer, Lilly Diabetes Drug Wins EU Panel’s Backing
Bloomberg
Fri, 03/21/14 - 09:41 am
Tags:
Jardiance, diabetes, Boehringer Ingelheim, Eli Lilly, Europe
Novo Nordisk sees chance of U.S. Tresiba launch before rival products
Yahoo/Reuters
Thu, 03/20/14 - 05:35 pm
Tags:
Novo Nordisk, insulin, diabetes, Tresiba, Lantus, Sanofi, Eli Lilly
Can Biogen Catch up to Merck in Alzheimer's Race?
Motley Fool
Wed, 03/12/14 - 02:58 pm
Tags:
Biogen Idec, Merck, Alzheimer's disease, E2609, bapineuzumab, LY2886721, Eli Lilly, Tecfidera
Four Upcoming Catalysts That Could Move Pharmaceutical Stocks
Yahoo/24-7 Wall St
Mon, 03/10/14 - 10:13 am
Tags:
Eli Lilly, Bristol-Myers Squibb, Merck, Pfizer, Yervoy, palbociclib, animal health, ramucirumab
What Does This Rejection Mean for Eli Lilly?
Motley Fool
Fri, 03/7/14 - 09:24 am
Tags:
Eli Lilly, FDA, empagliflozin, Boehringer Ingelheim
Can Merck Outperform AbbVie and Eli Lilly in 2014?
Motley Fool
Thu, 03/6/14 - 11:36 am
Tags:
AbbVie, Eli Lilly, Merck
Can Diabetes Treatments Replace Patent Losses At Eli Lilly & Co?
Motley Fool
Thu, 03/6/14 - 10:17 am
Tags:
Eli Lilly, diabetes, patents, dulaglutide, GLP-1 agonist, Novo Nordisk, AstraZeneca, GSK, JNJ
Lilly’s Diabetes Pill Rejected by FDA Over Manufacturing
Bloomberg
Wed, 03/5/14 - 11:44 am
Tags:
FDA, Eli Lilly, diabetes, empagliflozin, Boehringer Ingelheim
Lilly, Pfizer and Merck slash doctor payments, but J&J and Forest shell out more
Fierce Pharma
Tue, 03/4/14 - 10:30 pm
Tags:
physician payments, Pfizer, Merck, JNJ, Forest Labs, Eli Lilly
Teva announces approval of generic to Lilly's Evista
The Fly on the Wall
Tue, 03/4/14 - 12:26 pm
Tags:
Teva Pharmaceuticals, Eli Lilly, Evista, generics
3 Top Pharmaceuticals: Patents, Pipelines And Prospects
Seeking Alpha
Mon, 03/3/14 - 10:06 am
Tags:
patents, JNJ, Eli Lilly, Pfizer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.